オレオイル-ACPヒドローラゼの高い発現は,生命を脅かす呼吸器ウイルス疾患を支えている
Xiaoxiao Jia1, Jeremy Chase Crawford2, Deborah Gebregzabher1
1Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Cell
|August 13, 2024
まとめ
オレオイル-アシル-キャリア-タンパク質 (ACP) ヒドローラゼ (OLAH) は重度の呼吸器感染症を誘発する. OLAH発現を低下させることで,致命的なインフルエンザから守られ,肺炎とウイルス負荷が軽減されます.
科学分野:
- ウイルス学
- 免疫学
- 生物化学
背景:
- 呼吸器感染症は著しい罹病率と死亡率を引き起こす.
- 重度の疾患の進行を促す正確なメカニズムは不明である.
- 早期の致死要因を特定することは 治療の介入に不可欠です
研究 の 目的:
- 致命的な鳥インフルエンザA ((H7N9) の初期分子要因を調査する.
- 重度の呼吸器ウイルス感染症におけるオレオイル-アシル-キャリア-タンパク質 (ACP) ヒドロラーゼ (OLAH) の役割を決定する.
主な方法:
- A ((H7N9) インフルエンザで入院した患者のトランスクリプトミア分析
- 死因と回復した患者および他の呼吸器感染症の重症と軽度の症例におけるOLAH発現の比較.
- インフルエンザに感染したOLAH欠乏症 (olah-/-) のマウスを用いた体内試験.
- ウイルス複製とマクロファージの炎症に対するオレイン酸の影響を評価するインビトロ研究.
主要な成果:
- 高いOLAH発現は,致命的なA ((H7N9) インフルエンザと,季節性インフルエンザ,COVID-19,RSV,MIS-Cの重篤なアウトカムと強く関連していた.
- オレラ-のマウスは,致命的なインフルエンザ感染中に死亡率,肺ウイルス負荷,組織損傷,および炎症を減少させた.
- OLAH欠乏したマウスでは,ウイルスの複製とマクロファージの炎症の減少が観察されました.
- オレイン酸補充はウイルスの複製とマクロファージの炎症の可能性を高めました.
結論:
- OLAH発現は,様々な呼吸器ウイルス感染症の重篤で致死的な結果の主要な要因です.
- OLAHをターゲットにすることは,重度の呼吸器ウイルス疾患を緩和するための新しい治療戦略を表す可能性があります.
- OLAHによって介される脂肪酸代謝の調節不良は,ウイルス病原化に寄与する.
関連する概念動画
Acute Respiratory Failure-III
166
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
166
Acute Respiratory Failure-V
126
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
126
Acute Respiratory Failure-I
180
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
180
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Acute Respiratory Failure-II
187
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
187
Acute Respiratory Failure-IV
132
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
132


